L. Maître

1.4k total citations
49 papers, 1.1k citations indexed

About

L. Maître is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, L. Maître has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 17 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in L. Maître's work include Neurotransmitter Receptor Influence on Behavior (18 papers), Neuroscience and Neuropharmacology Research (14 papers) and Receptor Mechanisms and Signaling (8 papers). L. Maître is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (18 papers), Neuroscience and Neuropharmacology Research (14 papers) and Receptor Mechanisms and Signaling (8 papers). L. Maître collaborates with scholars based in Switzerland, France and Germany. L. Maître's co-authors include P. C. Waldmeier, M. Staehelin, P. A. Baumann, E. Muscholl, H. J. Bein, Pierre Martin, R. Bernasconi, F. Raschdorf, Kathleen Hauser and Pierre Baumann and has published in prestigious journals such as Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.

In The Last Decade

L. Maître

47 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Maître Switzerland 20 626 376 231 154 136 49 1.1k
Albert N. Nelson United States 13 473 0.8× 484 1.3× 267 1.2× 255 1.7× 85 0.6× 24 1.2k
A. Sundwall Sweden 18 486 0.8× 378 1.0× 221 1.0× 58 0.4× 104 0.8× 46 1.0k
H. Coper Germany 19 575 0.9× 425 1.1× 233 1.0× 80 0.5× 190 1.4× 124 1.4k
J. Bruinvels Netherlands 19 416 0.7× 326 0.9× 112 0.5× 118 0.8× 131 1.0× 54 845
Bjarne Fjalland Denmark 18 520 0.8× 376 1.0× 153 0.7× 150 1.0× 131 1.0× 45 1.0k
Lillian E. Dyck Canada 19 569 0.9× 425 1.1× 110 0.5× 111 0.7× 167 1.2× 57 1.3k
Charles R. Craig United States 19 556 0.9× 287 0.8× 212 0.9× 231 1.5× 117 0.9× 41 1.0k
Leroy R. Reid United States 15 565 0.9× 337 0.9× 258 1.1× 115 0.7× 123 0.9× 18 1.0k
A. Revuelta United States 19 1.1k 1.7× 580 1.5× 188 0.8× 124 0.8× 224 1.6× 30 1.5k
Eric A. Muth United States 18 713 1.1× 519 1.4× 380 1.6× 168 1.1× 158 1.2× 24 1.4k

Countries citing papers authored by L. Maître

Since Specialization
Citations

This map shows the geographic impact of L. Maître's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Maître with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Maître more than expected).

Fields of papers citing papers by L. Maître

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Maître. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Maître. The network helps show where L. Maître may publish in the future.

Co-authorship network of co-authors of L. Maître

This figure shows the co-authorship network connecting the top 25 collaborators of L. Maître. A scholar is included among the top collaborators of L. Maître based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Maître. L. Maître is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bischoff, Serge, et al.. (1993). CGP 25454A, a novel dopamine autoreceptor antagonist. Schizophrenia Research. 9(2-3). 257–257. 1 indexed citations
2.
Bischoff, Serge, A. Bruinink, J. Krauss, et al.. (1992). CAN BRAIN REGION-SELECTIVE DOPAMINE (DA) RECEPTOR BLOCKERS PREFERENTIALLY ACT ON SCHIZOPHRENIA SUBTYPES?. Clinical Neuropharmacology. 15. 23A–24A. 2 indexed citations
3.
Bischoff, Serge, J. Krauss, Micheline Heinrich, et al.. (1991). Endogenous Dopamine (Da) Modulates [3H]spiperone Binding in Vivo in Rat Brain. Journal of Receptor Research. 11(1-4). 163–175. 19 indexed citations
4.
Waldmeier, P. C., et al.. (1990). Effects of the COMT inhibitor, CGP 28014, on plasma homovanillic acid and O-methylation of exogenous L-DOPA in the rat. PubMed. 32. 381–386. 19 indexed citations
5.
Boulat, Olivier, P. C. Waldmeier, & L. Maître. (1990). 3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: Effects of hydergine� and vincamine. Journal of Neural Transmission. 82(3). 181–195. 8 indexed citations
6.
Bernasconi, R., Christian Marescaux, M. Vergnes, et al.. (1988). Evaluation of the anticonvulsant and biochemical activity of CGS 8216 and CGS 9896 in animal models. Journal of Neural Transmission. 71(1). 11–27. 8 indexed citations
7.
Waldmeier, P. C., P. A. Baumann, H. Bittiger, et al.. (1984). CGP 15 210 G, AN UNUSUAL INHIBITOR OF SEROTONIN (5-HT) UPTAKE. Clinical Neuropharmacology. 7. S472–S472. 1 indexed citations
8.
Waldmeier, P. C., et al.. (1984). Carbamazepine decreases catecholamine turnover in the rat brain.. Journal of Pharmacology and Experimental Therapeutics. 231(1). 166–172. 24 indexed citations
9.
Maître, L., et al.. (1982). 5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.. PubMed. 34. 229–46. 23 indexed citations
10.
Waldmeier, P. C., P. A. Baumann, & L. Maître. (1979). CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.. Journal of Pharmacology and Experimental Therapeutics. 211(1). 42–49. 52 indexed citations
11.
Waldmeier, P. C. & L. Maître. (1979). The use of scopolamine for the estimation of the central antiacetylcholine properties of neuroleptics. Journal of Pharmacy and Pharmacology. 31(1). 553–555. 4 indexed citations
12.
Maître, L., et al.. (1978). [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(9). 1507–8.
13.
Baumann, Pierre, et al.. (1976). Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 52(3 suppl). 33–9. 54 indexed citations
14.
Waldmeier, P. C., et al.. (1974). Simultaneous automated estimation of noradrenaline and dopamine in brain tissue.. PubMed. 20(1). 81–3. 28 indexed citations
15.
Waldmeier, P. C., et al.. (1974). Simultaneous Automated Estimation of Noradrenaline and Dopamine in Brain Tissue. Clinical Chemistry. 20(1). 81–83. 28 indexed citations
16.
Maître, L., P. C. Waldmeier, & P. A. Baumann. (1973). Effects of some tetrahydrocannabinols on the biosynthesis and utilization of catecholamines in the rat brain. Life Sciences. 13(7). cxi–cxii. 8 indexed citations
17.
Maître, L., M. Staehelin, & H. J. Bein. (1971). Blockade of noradrenaline uptake by 34276-Ba, a new antidepressant drug. Biochemical Pharmacology. 20(9). 2169–2186. 44 indexed citations
18.
Maître, L., M. Staehelin, & H. Brünner. (1971). Antihypertensive and noradrenaline-depleting effects of guanethidine metabolites. Journal of Pharmacy and Pharmacology. 23(5). 327–331. 5 indexed citations
19.
Maître, L. & M. Staehelin. (1969). Über die3H-Noradrenalin-Aufnahme im Herzen und Gehirn von Küken. Naunyn-Schmiedeberg s Archives of Pharmacology. 264(3). 278–279. 1 indexed citations
20.
Maître, L. & M. Staehelin. (1967). On the norepinephrine replacement by α-methyl-norepinephrine in the rat heart after treatment with α-methyl-DOPA. Cellular and Molecular Life Sciences. 23(10). 810–811. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albert N. Nelson Breakdown of academic impact, for papers by A. Sundwall Breakdown of academic impact, for papers by H. Coper Breakdown of academic impact, for papers by J. Bruinvels Breakdown of academic impact, for papers by Bjarne Fjalland Breakdown of academic impact, for papers by Lillian E. Dyck Breakdown of academic impact, for papers by Charles R. Craig Breakdown of academic impact, for papers by Leroy R. Reid Breakdown of academic impact, for papers by A. Revuelta Breakdown of academic impact, for papers by Eric A. Muth
Rankless by CCL
2026